Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Drugs"
DOI: 10.1007/s40265-020-01295-y
Abstract: Atezolizumab (Tecentriq ® ), an immune checkpoint inhibitor against programmed death ligand 1 (PD-L1), is the first immunotherapy agent to be approved (for use in combination with nab-paclitaxel) in the USA, the EU (as first-line)… read more here.
Keywords: nab paclitaxel; combination nab; advanced triple; plus nab ... See more keywords
Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2016.11.012
Abstract: Sex Male 10 (83.3%) Female 2 (16.7%) Age (years), median (range) 61 (52—74) Comorbidities, median (range) 1.5 (1—4) Smoking 8 (66.7%) Diabetes mellitus 6 (50%) High blood pressure 5 (41.7%) Hyperlipidemia 2 (16.7%) Pancreatic tumor… read more here.
Keywords: nab paclitaxel; could combination; range; combination nab ... See more keywords